Gene expression profiling of multiple histone deacetylase (HDAC) inhibitors: defining a common gene set produced by HDAC inhibition in T24 and MDA carcinoma cell lines.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Molecular Cancer Therapeutics

• Publication date

  2003-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 12589032
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Sulfonamide anilides, a novel class of histone deacetylase inhibitors, are antiproliferative against human tumors.

  2002cited by this paper
• Expression profile analysis of trichostatin A in human gastric cancer cells

  2002cited by this paper
• Histone-deacetylase inhibitors: novel drugs for the treatment of cancer

  2002cited by this paper
• Transforming growth factor beta mimetics: discovery of 7-[4-(4-cyanophenyl)phenoxy]-heptanohydroxamic acid, a biaryl hydroxamate inhibitor of histone deacetylase.

  2002cited by this paper
• Genomic organization of the human gene HEP27: alternative promoter usage in HepG2 cells and monocyte-derived dendritic cells.

  2002cited by this paper
• Isolation and Characterization of Mammalian HDAC10, a Novel Histone Deacetylase*

  2002cited by this paper
• Ecteinascidin-743 inhibits activated but not constitutive transcription.

  2002cited by this paper
• HDAC6 is a microtubule-associated deacetylase

  2002cited by this paper
• Cloning and Functional Characterization of HDAC11, a Novel Member of the Human Histone Deacetylase Family*

  2002cited by this paper
• Potent histone deacetylase inhibitors built from trichostatin A and cyclic tetrapeptide antibiotics including trapoxin.

  2001cited by this paper
• Histone deacetylase inhibitors: development of suberoylanilide hydroxamic acid (SAHA) for the treatment of cancers.

  2001cited by this paper
• Negative control of p53 by Sir2alpha promotes cell survival under stress.

  2001cited by this paper
• Genes modulated by histone acetylation as new effectors of butyrate activity

  2001cited by this paper
• Inhibitors of histone deacetylase arrest cell cycle and induce apoptosis in cervical carcinoma cells circumventing human papillomavirus oncogene expression

  2001cited by this paper
• Chromatin remodeling: why it is important in cancer

  2001cited by this paper
• Negative Control of p53 by Sir2 Promotes Cell Survival under Stress

  2001cited by this paper
• Signal transduction pathways and the modification of chromatin structure.

  2001cited by this paper
• Cloning and characterization of a histone deacetylase, HDAC9

  2001cited by this paper
• hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase.

  2001cited by this paper
• Thymidylate synthase as a molecular target for drug discovery using the National Cancer Institute's Anticancer Drug Screen

  2001cited by this paper
• Class II histone deacetylases: structure, function, and regulation.

  2001cited by this paper
• The human histone deacetylase family.

  2001cited by this paper
• Histone deacetylase inhibitors induce remission in transgenic models of therapy-resistant acute promyelocytic leukemia.

  2001cited by this paper
• Phylogenetic classification of prokaryotic and eukaryotic Sir2-like proteins.

  2000cited by this paper
• Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase

  2000cited by this paper
• Suberoylanilide hydroxamic acid, an inhibitor of histone deacetylase, suppresses the growth of prostate cancer cells in vitro and in vivo.

  2000cited by this paper
• Genetic reprogramming in pathways of colonic cell maturation induced by short chain fatty acids: comparison with trichostatin A, sulindac, and curcumin and implications for chemoprevention of colon cancer.

  2000cited by this paper
• Histone deacetylase inhibitor selectively induces p21WAF1 expression and gene-associated histone acetylation.

  2000cited by this paper
• Suberoylanilide Hydroxamic Acid as a Potential Therapeutic Agent for Human Breast Cancer Treatment

  2000cited by this paper
• Histone deacetylase inhibitors: inducers of differentiation or apoptosis of transformed cells.

  2000cited by this paper
• Histone deacetylase inhibitors trigger a G2 checkpoint in normal cells that is defective in tumor cells.

  2000cited by this paper
• Nuclear clusterin/XIP8, an x-ray-induced Ku70-binding protein that signals cell death.

  2000cited by this paper
• The silencing protein SIR2 and its homologs are NAD-dependent protein deacetylases.

  2000cited by this paper
• A synthetic inhibitor of histone deacetylase, MS-27-275, with marked in vivo antitumor activity against human tumors.

  1999cited by this paper
• Anti-tumour activity in vitro and in vivo of selective differentiating agents containing hydroxamate

  1999cited by this paper
• Chemoprevention of carcinogen-induced mammary tumorigenesis by the hybrid polar cytodifferentiation agent, suberanilohydroxamic acid (SAHA).

  1999cited by this paper
• Histone Deacetylase Inhibition Selectively Alters the Activity and Expression of Cell Cycle Proteins Leading to Specific Chromatin Acetylation and Antiproliferative Effects*

  1999cited by this paper
• Induction of apoptosis in U937 human leukemia cells by suberoylanilide hydroxamic acid (SAHA) proceeds through pathways that are regulated by Bcl-2/Bcl-XL, c-Jun, and p21CIP1, but independent of p53

  1999cited by this paper
• Therapeutic targeting of transcription in acute promyelocytic leukemia by use of an inhibitor of histone deacetylase.

  1998cited by this paper
• Role of the histone deacetylase complex in acute promyelocytic leukaemia

  1998cited by this paper
• Fusion proteins of the retinoic acid receptor-α recruit histone deacetylase in promyelocytic leukaemia

  1998cited by this paper
• A class of hybrid polar inducers of transformed cell differentiation inhibits histone deacetylases.

  1998cited by this paper
• The expression of a small fraction of cellular genes is changed in response to histone hyperacetylation.

  1996cited by this paper
• A nuclear protein, synthesized in growth-arrested human hepatoblastoma cells, is a novel member of the short-chain alcohol dehydrogenase family.

  1995cited by this paper
• Identification of a novel nuclear protein synthesized in growth-arrested human hepatoblastoma HepG2 cells.

  1991cited by this paper
• Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A.

  1990cited by this paper

• Differential regulatory mechanisms of gut-derived SCFAs (acetate, propionate, butyrate) on the pulmonary TLR2 signaling pathway and their roles in the inflammatory balance of bacterial pneumonia

  2026cites this paper
• Histone Deacetylase Inhibitors Promote the Anticancer Activity of Cisplatin: Mechanisms and Potential

  2025cites this paper
• Therapeutic potential of HDAC inhibitors in a xenograft model of cancers: A special focus on breast cancer.

  2025cites this paper
• Loss of negative regulation by HDAC1 and REST contributes to MAD1 overexpression in breast cancer.

  2025cites this paper
• Epigenetic regulation of the tumor microenvironment in lung cancer: mechanism insights and therapeutic prospects

  2025cites this paper
• aiGeneR 1.0: An Artificial Intelligence Technique for the Revelation of Informative and Antibiotic Resistant Genes in Escherichia coli.

  2024cites this paper
• Opportunities and Difficulties in the Repurposing of HDAC Inhibitors as Antiparasitic Agents

  2024cites this paper
• Romidepsin and afatinib abrogate JAK-STAT signaling and elicit synergistic antitumor effects in cutaneous T-cell lymphoma.

  2024cites this paper
• The role of HDAC3 in inflammation: mechanisms and therapeutic implications

  2024cites this paper
• A comprehensive characterization of the dehydrogenase-reductase DHRS2 and its involvement in histone deacetylase inhibition.

  2024cites this paper
• A Pilot Study of the Combination of Entinostat with Capecitabine in Advanced Breast Cancer

  2024cites this paper
• The main protease of SARS-CoV-2 cleaves histone deacetylases and DCP1A, attenuating the immune defense of the interferon-stimulated genes

  2023influential citation
• Factor-specific generative pattern from large-scale drug-induced gene expression profile

  2023cites this paper
• Expanding the HDAC druggable landscape beyond enzymatic activity

  2023cites this paper
• Disrupted Stiffness Ratio Alters Nuclear Mechanosensing.

  2023cites this paper
• Emerging Role of Epigenetic Modifiers in Breast Cancer Pathogenesis and Therapeutic Response

  2023cites this paper
• Potential of histone deacetylase inhibitors in the control and regulation of prostate, breast and ovarian cancer

  2022cites this paper
• Proteomics-based trapping with single or multiple inactive mutants reproducibly profiles histone deacetylase 1 substrates.

  2022cites this paper
• Tau Stabilizes Chromatin Compaction

  2021cites this paper
• Inhibition of myeloid HDAC2 upregulates glutaredoxin 1 expression, improves protein thiol redox state and protects against high-calorie diet-induced monocyte dysfunction and atherosclerosis.

  2021cites this paper
• A Rare Presentation of a Non-Asian Female With Metastatic Non-small-cell Lung Cancer Harboring EGFR L747P Mutation With Clinical Response to Multi-targeted Epigenetic and EGFR Inhibition

  2021cites this paper
• Modulation of cathelicidin and defensins by histone deacetylase inhibitors: a potential treatment for multi-drug resistant infectious diseases.

  2021cites this paper
• Phase 1 trial of entinostat as monotherapy and combined with exemestane in Japanese patients with hormone receptor-positive advanced breast cancer

  2021cites this paper
• Targeting Epigenetic Modifiers Can Reduce the Clonogenic Capacities of Sézary Cells

  2021cites this paper
• DNA methylation and demethylation underlie the sex difference in estrogen receptor alpha in the arcuate nucleus

  2021cites this paper
• Targeting (de)acetylation: A Diversity of Mechanism and Disease

  2021cites this paper
• Butyrate inhibits human mast cell activation via epigenetic regulation of FcεRI‐mediated signaling

  2020cites this paper
• Epigenetic Regulation of MDR1 and BCRP Transporters by HDAC Inhibition

  2020cites this paper
• Epigenetic Regulation of MDR1 and BCRP Transporters by HDAC Inhibition.

  2020cites this paper
• Screening of Chrysin and its Derivatives for their Binding Affinity to Human Histone Deacetylases (Hdacs): A Computer-Aided Approach

  2020cites this paper
• Present and future perspectives for targeting histone modifications in therapy

  2020cites this paper
• The Effect of Sodium Butyrate on Adventitious Shoot Formation Varies among the Plant Species and the Explant Types

  2020cites this paper
• Histone deacetylase inhibition enhances the therapeutic effects of methotrexate on primary central nervous system lymphoma

  2020cites this paper
• Identification of histone deacetylase inhibitors with (arylidene)aminoxy scaffold active in uveal melanoma cell lines

  2020cites this paper
• Deconvolution of cell type-specific drug responses in human tumor tissue with single-cell RNA-seq

  2020cites this paper
• HDAC inhibitors decrease TLR7/9-mediated human plasmacytoid dendritic cell activation by interfering with IRF-7 and NF-κB signaling

  2020cites this paper
• New horizons in benzothiazole scaffold for cancer therapy: Advances in bioactivity, functionality, and chemistry

  2020cites this paper
• Extensive proteomic and transcriptomic changes quench the TCR/CD3 activation signal of latently HIV-1 infected T cells

  2020cites this paper
• Cardiovascular Effects of Cancer Therapy

  2020cites this paper
• Breast Cancer Prevention-Is there a Future for Sulforaphane and Its Analogs?

  2020cites this paper
• The Cancer Epigenome: Exploiting Its Vulnerabilities for Immunotherapy.

  2019cites this paper
• Integrated chromatin and transcriptomic profiling of patient-derived colon cancer organoids identifies personalized drug targets to overcome oxaliplatin resistance

  2019cites this paper
• Histone Deacetylase Modifications by Probiotics in Colorectal Cancer

  2019cites this paper
• Histone deacetylase inhibitors differentially regulate c-Myc expression in retinoblastoma cells

  2019cites this paper
• The Role of Activating Transcription Factor 3 as a Regulator of DNA-Damaging Chemotherapy Cytotoxicity

  2019cites this paper
• Restoring T Cell Tolerance, Exploring the Potential of Histone Deacetylase Inhibitors for the Treatment of Juvenile Idiopathic Arthritis

  2019cites this paper
• Disruption of the Molecular Circadian Clock and Cancer: An Epigenetic Link

  2019cites this paper
• Resistance to Histone Deacetylase Inhibitors in the Treatment of Lymphoma

  2019cites this paper
• Epigenetic Modifications in Acute Myeloid Leukemia: Prognosis, Treatment, and Heterogeneity

  2019cites this paper
• Valproic Acid Contributes to Bone Cavity Healing in Rats

  2019cites this paper
• A phase I pharmacokinetic study of belinostat in patients with advanced cancers and varying degrees of liver dysfunction

  2019cites this paper
• The role of histone deacetylase inhibitors in metastatic breast cancer.

  2019cites this paper
• HDAC7 regulates histone 3 lysine 27 acetylation and transcriptional activity at super-enhancer-associated genes in breast cancer stem cells

  2019cites this paper
• Revisiting Histone Deacetylases in Human Tumorigenesis: The Paradigm of Urothelial Bladder Cancer

  2019cites this paper
• Suberoylanilide Hydroxamic Acid Can Re-sensitize a Cisplatin-Resistant Human Bladder Cancer.

  2019cites this paper
• Neonatal inhibition of DNA methylation disrupts testosterone-dependent masculinization of neurochemical phenotype.

  2019cites this paper
• Histone Deacetylase Inhibitors in Cancer Therapy.

  2019cites this paper
• MYC competes with MiT/TFE in regulating lysosomal biogenesis and autophagy through an epigenetic rheostat

  2019cites this paper
• miR-665 targets c-MYC and HDAC8 to inhibit murine neuroblastoma cell growth

  2018cites this paper
• Proteomic analysis identifies NPTX1 and HIP1R as potential targets of histone deacetylase-3-mediated neurodegeneration

  2018cites this paper
• Investigation of non-hydroxamate scaffolds against HDAC6 inhibition: A pharmacophore modeling, molecular docking, and molecular dynamics simulation approach

  2018cites this paper
• Dietary modulation of endogenous host defense peptide synthesis as an alternative approach to in-feed antibiotics

  2018cites this paper
• HDAC as onco target: Reviewing the synthetic approaches with SAR study of their inhibitors.

  2018cites this paper
• SUV39H2 promotes colorectal cancer proliferation and metastasis via tri-methylation of the SLIT1 promoter.

  2018cites this paper
• HDAC inhibitors show differential epigenetic regulation and cell survival strategies on p53 mutant colon cancer cells

  2018cites this paper
• Anti-tumor activity of phenoxybenzamine and its inhibition of histone deacetylases

  2018influential citation
• Curcumin Derivative Epigenetically Reactivates Nrf2 Antioxidative Stress Signaling in Mouse Prostate Cancer TRAMP C1 Cells.

  2018cites this paper
• CUDC-907, a dual HDAC and PI3K inhibitor, reverses platinum drug resistance

  2018cites this paper
• Dual HDAC and PI3K Inhibition Abrogates NFκB- and FOXM1-Mediated DNA Damage Response to Radiosensitize Pediatric High-Grade Gliomas.

  2018cites this paper
• Epigenetic Regulation via Altered Histone Acetylation Results in Suppression of Mast Cell Function and Mast Cell-Mediated Food Allergic Responses

  2018cites this paper
• Deciphering the molecular effects of romidepsin on germ cell tumours: DHRS2 is involved in cell cycle arrest but not apoptosis or induction of romidepsin effectors

  2018cites this paper
• Epigenetic regulation of vascular NADPH oxidase expression and reactive oxygen species production by histone deacetylase-dependent mechanisms in experimental diabetes

  2018cites this paper
• A novel approach to eliminate therapy-resistant mantle cell lymphoma: synergistic effects of Vorinostat with Palbociclib

  2018cites this paper
• Histone deacetylase activity is required for Botrylloides leachii whole-body regeneration

  2018cites this paper
• The latest evidence for possible HIV-1 curative strategies

  2018cites this paper
• Design, Synthesis, Molecular Modeling, and Biological Evaluation of Novel Amine‐based Histone Deacetylase Inhibitors

  2017cites this paper
• Transcriptional Profiling Defines Histone Acetylation as a Regulator of Gene Expression during Human-to-Mosquito Transmission of the Malaria Parasite Plasmodium falciparum

  2017cites this paper
• Epigenetic Activation of μ-Opioid Receptor Gene via Increased Expression and Function of Mitogen- and Stress-Activated Protein Kinase 1

  2017cites this paper
• Epigenetic regulation in bacterial infections: targeting histone deacetylases

  2017cites this paper
• Reversal of platinum drug resistance by the histone deacetylase inhibitor belinostat.

  2017cites this paper
• Novel Class IIa-Selective Histone Deacetylase Inhibitors Discovered Using an in Silico Virtual Screening Approach

  2017cites this paper
• Development of Potent Type I Protein Arginine Methyltransferase (PRMT) Inhibitors of Leukemia Cell Proliferation.

  2017cites this paper
• HDACs and HDAC Inhibitors in Urothelial Carcinoma - Perspectives for an Antineoplastic Treatment.

  2017cites this paper
• Cellular analysis of the action of epigenetic drugs and probes

  2017cites this paper
• Molecular mechanisms of histone deacetylases in rheumatoid arthritis fibroblast-like synoviocytes

  2017cites this paper
• The impact of cruciferous vegetable isothiocyanates on histone acetylation and histone phosphorylation in bladder cancer.

  2017cites this paper
• Epigenetic Regulation of Interleukin 6 by Histone Acetylation in Macrophages and Its Role in Paraquat-Induced Pulmonary Fibrosis

  2017cites this paper
• Lysine Deacetylase Inhibitors in Parasites: Past, Present, and Future Perspectives.

  2017cites this paper
• Regulation of the Glycerol Transporter, Aquaporin-3, by Histone Deacetylase-3 and p53 in Keratinocytes.

  2017cites this paper
• Epigenetic activation of mu opioid receptor ( MOR ) gene via increased expression and function of mitogen-and stress-activated protein kinase 1 ( MSK 1 )

  2017cites this paper
• Influência de gênero no desenvolvimento somático e sensório motor de ratos wistar submetidos à anóxia neonatal

  2017cites this paper
• Differentiation of human adipose-derived stem cells into cardiomyocyte-like cells in fibrin scaffold by a histone deacetylase inhibitor

  2017cites this paper
• Neonatal Inhibition of DNA Methylation Alters Cell Phenotype in Sexually Dimorphic Regions of the Mouse Brain

  2017cites this paper
• Scaffold dependent histone deacetylase (HDAC) inhibitor induced re-equilibration of the subcellular localization and post-translational modification state of class I HDACs

  2017cites this paper
• Targeting lysine acetylation in inflammatory lung diseases

  2017cites this paper
• Targeting transcription factor lysine acetylation in inflammatory airway diseases.

  2017cites this paper
• Transcriptional regulation by the oncoprotein STAT5: role of acetylation and deacetylation processes

  2017cites this paper
• Stress management : multilayer regulation of the heat shock response

  2017cites this paper
• Histone deacetylase inhibitor SAHA mediates mast cell death and epigenetic silencing of constitutively active D816V KIT in systemic mastocytosis

  2016cites this paper
• CRISPR-mediated Activation of Latent HIV-1 Expression.

  2016cites this paper